Gastric cancer (GC) ranks fifth in global cancer incidence, causing over 650,000 deaths annually. The clinical management of this disease has long been hampered by a scarcity of effective early screening tools—most patients are first diagnosed at advanced stages, when the therapeutic window is extremely narrow. Our team has systematically profiled the virome in blood and fecal samples from gastric cancer patients, delineating the virological landscape of the disease.
“In healthy individuals, the blood virome is dominated by bacteriophages—viruses that infect bacteria,” explains Dr. Wang Li, corresponding author of a new study published in Virologica Sinica . “But in gastric cancer patients, over 80% of viral sequences belong to a single family, Anelloviridae —viruses that infect humans but rarely cause disease. At the same time, viral diversity plummets, as if an entire ecosystem is being taken over by one species.”
The researchers identified 67 provisional novel anellovirus species and one entirely new virus, a gemykibivirus, in the blood of gastric cancer patients, greatly expanding our understanding of the hidden diversity of the human blood virome.
“Interestingly, the gut told a different story,” says Li. “While blood diversity declined, the gut virome of cancer patients showed increased diversity, with a mix of bacteriophages that different body compartments respond to cancer in distinct ways.”
“This indicates that the virome is not a single entity but is compartment‑specific, with each site following its own ecological rules,” says co‑corresponding author Dr. Shaokun Pan.
The most clinically translatable finding came from LEfSe analysis, which identified Betatorquevirus, a genus within Anelloviridae , as a key viral signature distinguishing gastric cancer patients from healthy individuals. Network analyses further revealed that anelloviruses negatively correlate with multiple bacteriophage families, suggesting they may outcompete other viruses in the bloodstream.
“The expansion of blood anelloviruses holds promise as a non‑invasive biomarker for gastric cancer,” adds Li. “Whether this virus can serve as a non‑invasive biomarker requires larger prospective studies to validate its clinical utility.”
This study provides the first comprehensive atlas of blood and gut virome remodeling in gastric cancer, offering new insights into fundamental biology and laying a foundation for the development of future diagnostic tools. The team has made all data publicly available to accelerate further research in this emerging field.
###
Contact the author:
Dr. Wang Li
The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China
liwang20091221@126.com
Dr. Shaokun Pan
Fudan University
skpan@fudan.edu.cn
The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).
Virologica Sinica
Data/statistical analysis
Human tissue samples
Blood and gut virome remodeling in gastric cancer: Anellovirus expansion and novel virus discovery
The authors disclose no potential conflicts of interest, whether financial or non-financial, associated with the research, authorship, and publication of this manuscript.